Telemedicine Technologies is an engineering company specialising in eHealth information systems, a fast-growing sector with many opportunities.
Telemedicine Technologies’ activity is a mix of various disciplines (Software engineering, space technologies, big data and data science, medicine and clinical operations …) in an international environment and a start-up spirit.
Telemedicine Technologies develops and provides solutions that contribute to improving the care system, patient monitoring and clinical aspects in a wide variety of uses.
Join us
You will be part of our software development team or will work on projects for our health sectors clients: pharmaceutical companies, Biotechs, Medtechs, CROs, public hospitals, patient associations…
You could also work on collaborative R&D projects or international programmes
Internship or young graduate, your aim is to obtain new skills, to fully understand the business, the solutions, and Telemedicine Technologies methods. You will also be responsible for: writing software development specifications, developing, testing, validating, configuration and training.
You will be trained in the methodologies, working environment (Hibernate, VAADIN) standards (CDISC), and the quality assurance processes of Telemedicine Technologies Quickly gaining experience, you will use your knowledge and experience to carry out development tasks or increasingly complex project activities.
As a manager you will lead a development team, or you will be in charge of a project to deliver a solution and services that meet all expectations.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
February 29, 2024
4 and 5 march 2024 TELEMEDICINE TECHNOLOGIES is delighted to announce its participation in the upcoming ACDM24 conference, the largest European event in clinical data management for 2024! Join us in Copenhagen from March 3rd to 5th, where industry leaders and experts will gather to explore the latest trends in the field. Christophe Golenvaux and […]
February 29, 2024
Bio Pharm International FDA’s Drug Safety Priorities FY23 describes the center’s key safety programs and activities involved in promoting and protecting public health. On Feb. 15, 2024, FDA’s Center for Drug Evaluation and Research (CDER) released its report, Drug Safety Priorities FY23. The report describes the center’s key safety programs and activities involved in promoting and […]
February 29, 2024
Fierce Biotech In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, multidisciplinary, and cost-effective approaches. Pathways have become a critical strategy for both physicians and payers to streamline treatment decision-making, standardize evidence-based care, improve patient outcomes […]